[HTML][HTML] The global burden of metabolic disease: Data from 2000 to 2019
Global estimates of prevalence, deaths, and disability-adjusted life years (DALYs) from the
Global Burden of Diseases, Injuries, and Risk Factors Study 2019 were examined for …
Global Burden of Diseases, Injuries, and Risk Factors Study 2019 were examined for …
Unveiling the cancer risk nexus of the steatotic liver
Steatotic liver, characterized by the accumulation of fat in the liver, poses significant health
risks including metabolic dysfunction-associated steatotic liver disease (MASLD) and an …
risks including metabolic dysfunction-associated steatotic liver disease (MASLD) and an …
[HTML][HTML] Global incidence of adverse clinical events in non-alcoholic fatty liver disease: A systematic review and meta-analysis
MH Le, DM Le, TC Baez, H Dang… - Clinical and …, 2024 - ncbi.nlm.nih.gov
Methods We performed a systematic review and meta-analysis of cohort studies of adults
with NAFLD to evaluate the pooled incidence of adverse events. Results 19,406 articles …
with NAFLD to evaluate the pooled incidence of adverse events. Results 19,406 articles …
Hepatic steatosis and advanced hepatic fibrosis are independent predictors of long‐term mortality in acute myocardial infarction
YH Chin, J Lim, G Kong, CH Ng, R Goh… - Diabetes, Obesity …, 2023 - Wiley Online Library
Aim To examine the prevalence and prognosis of hepatic steatosis and fibrosis in post‐
acute myocardial infarction (AMI) patients. Methods Patients presenting with AMI to a tertiary …
acute myocardial infarction (AMI) patients. Methods Patients presenting with AMI to a tertiary …
The prognostic value of including non‐alcoholic fatty liver disease in the definition of metabolic syndrome
CE Fu, JN Yong, CH Ng, B Nah… - Alimentary …, 2023 - Wiley Online Library
Summary Background/Aims Metabolic syndrome (MetS) affects over one third of the US
adult population. Despite its close association with non‐alcoholic fatty liver disease …
adult population. Despite its close association with non‐alcoholic fatty liver disease …
Integrative multiomics enhancer activity profiling identifies therapeutic vulnerabilities in cholangiocarcinoma of different etiologies
Objectives Cholangiocarcinoma (CCA) is a heterogeneous malignancy with high mortality
and dismal prognosis, and an urgent clinical need for new therapies. Knowledge of the CCA …
and dismal prognosis, and an urgent clinical need for new therapies. Knowledge of the CCA …
the heart of NAFLD
NWS Chew, S Kannan, B Chong, Y Chin… - Frontiers in …, 2023 - frontiersin.org
The silent obesity epidemic has led to the rising global prevalence of non-alcoholic fatty liver
disease (NAFLD). This metabolic burden is a growing public health concern as forecast …
disease (NAFLD). This metabolic burden is a growing public health concern as forecast …
[HTML][HTML] EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
Metabolic dysfunction-associated steatotic liver disease (MASLD), previously termed non-
alcoholic fatty liver disease (NAFLD), is defined as steatotic liver disease (SLD) in the …
alcoholic fatty liver disease (NAFLD), is defined as steatotic liver disease (SLD) in the …
Relationship between non-alcoholic fatty liver disease and visceral fat measured by imaging-based body composition analysis: a systematic review
Imaging-based body composition analysis can quantify visceral fat, which is an important
feature of lean non-alcoholic fatty liver disease (NAFLD) patients. This review assesses …
feature of lean non-alcoholic fatty liver disease (NAFLD) patients. This review assesses …
Defining an approach for therapeutic strategies in metabolic dysfunction-associated steatotic liver disease after liver transplantation
Occurrence of metabolic dysfunction associated steatotic liver (MASLD) is common following
liver transplantation (LT). MASLD can be classified as recurrent disease when it occurs in …
liver transplantation (LT). MASLD can be classified as recurrent disease when it occurs in …